vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $197.1M, roughly 1.4× Citi Trends Inc). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -3.5%, a 4.2% gap on every dollar of revenue. On growth, Citi Trends Inc posted the faster year-over-year revenue change (10.1% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $767.0K).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
CTRN vs HCM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $270.8M |
| Net Profit | $-6.9M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | -3.7% | -13.2% |
| Net Margin | -3.5% | 0.7% |
| Revenue YoY | 10.1% | -16.5% |
| Net Profit YoY | 3.6% | -83.6% |
| EPS (diluted) | $-0.86 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $197.1M | $270.8M | ||
| Q3 25 | $190.8M | — | ||
| Q2 25 | $201.7M | $277.7M | ||
| Q1 25 | $211.2M | $324.5M | ||
| Q4 24 | $179.1M | — | ||
| Q3 24 | $176.6M | — | ||
| Q2 24 | $186.3M | $305.7M | ||
| Q1 24 | $215.2M | — |
| Q4 25 | $-6.9M | $2.0M | ||
| Q3 25 | $3.8M | — | ||
| Q2 25 | $871.0K | $455.0M | ||
| Q1 25 | $-14.2M | $11.9M | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $-18.4M | — | ||
| Q2 24 | $-3.4M | $25.8M | ||
| Q1 24 | $3.6M | — |
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% | ||
| Q1 24 | — | — |
| Q4 25 | -3.7% | -13.2% | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 0.2% | -1.3% | ||
| Q1 25 | 0.6% | -5.0% | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | -14.1% | — | ||
| Q2 24 | -3.7% | -9.0% | ||
| Q1 24 | 1.8% | — |
| Q4 25 | -3.5% | 0.7% | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.4% | 163.8% | ||
| Q1 25 | -6.7% | 3.7% | ||
| Q4 24 | -4.0% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -1.8% | 8.4% | ||
| Q1 24 | 1.7% | — |
| Q4 25 | $-0.86 | $0.00 | ||
| Q3 25 | $0.46 | — | ||
| Q2 25 | $0.11 | $0.52 | ||
| Q1 25 | $-1.70 | $0.01 | ||
| Q4 24 | $-0.86 | — | ||
| Q3 24 | $-2.21 | — | ||
| Q2 24 | $-0.42 | $0.03 | ||
| Q1 24 | $0.43 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $107.8M | $1.2B |
| Total Assets | $464.3M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $802.5M | ||
| Q1 24 | — | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — |
| Q4 25 | $107.8M | $1.2B | ||
| Q3 25 | $113.2M | — | ||
| Q2 25 | $108.6M | $1.2B | ||
| Q1 25 | $113.2M | $759.9M | ||
| Q4 24 | $130.3M | — | ||
| Q3 24 | $136.6M | — | ||
| Q2 24 | $154.8M | $740.1M | ||
| Q1 24 | $157.7M | — |
| Q4 25 | $464.3M | $1.8B | ||
| Q3 25 | $457.4M | — | ||
| Q2 25 | $437.4M | $1.8B | ||
| Q1 25 | $462.8M | $1.3B | ||
| Q4 24 | $467.1M | — | ||
| Q3 24 | $506.7M | — | ||
| Q2 24 | $484.1M | $1.3B | ||
| Q1 24 | $518.7M | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | $8.2M |
| Free Cash FlowOCF − Capex | $767.0K | $3.4M |
| FCF MarginFCF / Revenue | 0.4% | 1.2% |
| Capex IntensityCapex / Revenue | 4.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $8.2M | ||
| Q3 25 | $3.9M | — | ||
| Q2 25 | $-11.0M | $-72.9M | ||
| Q1 25 | $28.5M | $40.3M | ||
| Q4 24 | $-18.4M | — | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $-19.6M | $-39.8M | ||
| Q1 24 | $23.3M | — |
| Q4 25 | $767.0K | $3.4M | ||
| Q3 25 | $-1.7M | — | ||
| Q2 25 | $-13.1M | $-82.2M | ||
| Q1 25 | $26.0M | $32.5M | ||
| Q4 24 | $-20.4M | — | ||
| Q3 24 | $1.7M | — | ||
| Q2 24 | $-21.2M | $-49.9M | ||
| Q1 24 | $20.0M | — |
| Q4 25 | 0.4% | 1.2% | ||
| Q3 25 | -0.9% | — | ||
| Q2 25 | -6.5% | -29.6% | ||
| Q1 25 | 12.3% | 10.0% | ||
| Q4 24 | -11.4% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | -11.4% | -16.3% | ||
| Q1 24 | 9.3% | — |
| Q4 25 | 4.0% | 1.8% | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 1.0% | 3.3% | ||
| Q1 25 | 1.2% | 2.4% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 0.9% | 3.3% | ||
| Q1 24 | 1.5% | — |
| Q4 25 | — | 4.21× | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | -12.59× | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.54× | ||
| Q1 24 | 6.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
